Latest Insider Transactions at Oncocyte Corp (OCX)
This section provides a real-time view of insider transactions for Oncocyte Corp (OCX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oncocyte Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oncocyte Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
Andrea S. James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+27.15%
|
$40,000
$2.29 P/Share
|
|
Oct 02
2024
|
Andrea S. James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,670
+50.0%
|
$67,340
$2.97 P/Share
|
|
Oct 02
2024
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Oct 02
2024
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,315,339
+17.4%
|
$2,630,678
$2.95 P/Share
|
|
Apr 11
2024
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 11
2024
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,420,000
+32.93%
|
$4,840,000
$2.92 P/Share
|
|
Apr 11
2024
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Direct |
33,898
+32.93%
|
$67,796
$2.95 P/Share
|
|
Apr 11
2024
|
Josh Riggs CEO and President |
BUY
Open market or private purchase
|
Direct |
3,390
+49.17%
|
$6,780
$2.95 P/Share
|
|
Jun 30
2023
|
John Peter Gutfreund |
SELL
Other acquisition or disposition
|
Indirect |
3,085,047
-100.0%
|
-
|
|
Jun 23
2023
|
Lou Silverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+44.43%
|
-
|
|
Jun 23
2023
|
Alfred D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+3.93%
|
-
|
|
Jun 23
2023
|
Andrew J. Last Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+18.15%
|
-
|
|
Jun 23
2023
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+4.09%
|
-
|
|
Jun 14
2023
|
Alfred D Kingsley Director |
BUY
Open market or private purchase
|
Direct |
30,000
+6.01%
|
$0
$0.21 P/Share
|
|
Apr 05
2023
|
Pura Vida Investments, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
663,000
+7.57%
|
$0
$0.3 P/Share
|
|
Apr 03
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 03
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
26,827,638
+34.84%
|
$0
$0.3 P/Share
|
|
Apr 03
2023
|
John Peter Gutfreund |
BUY
Grant, award, or other acquisition
|
Indirect |
1,000,000
+48.19%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
John Peter Gutfreund |
BUY
Grant, award, or other acquisition
|
Direct |
705,000
+49.65%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Indirect |
282,168
+47.48%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
141,084
+17.33%
|
$0
$0.35 P/Share
|
|
Mar 06
2023
|
Pura Vida Investments, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,890,111
-45.88%
|
-
|
|
Dec 23
2022
|
John Peter Gutfreund |
BUY
Open market or private purchase
|
Indirect |
75,000
+50.0%
|
$0
$0.33 P/Share
|
|
Dec 23
2022
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Direct |
250,000
+31.97%
|
$0
$0.35 P/Share
|
|
Dec 22
2022
|
Alfred D Kingsley Director |
BUY
Open market or private purchase
|
Direct |
25,000
+5.39%
|
$0
$0.28 P/Share
|
|
Dec 21
2022
|
Douglas T. Ross Former CSO |
BUY
Grant, award, or other acquisition
|
Direct |
213,797
+47.73%
|
-
|
|
Dec 01
2022
|
Gisela Paulsen Former President and COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
175,000
-32.32%
|
-
|
|
Dec 01
2022
|
Douglas T. Ross Former CSO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
150,000
-88.07%
|
-
|
|
Dec 01
2022
|
Ronald Asbury Andrews Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+30.0%
|
-
|
|
Aug 17
2022
|
Andrew J. Last Director |
BUY
Open market or private purchase
|
Direct |
20,000
+22.18%
|
$0
$0.87 P/Share
|
|
Aug 17
2022
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+33.33%
|
$0
$0.9 P/Share
|
|
Aug 16
2022
|
Ronald Asbury Andrews Former CEO |
BUY
Open market or private purchase
|
Direct |
40,000
+10.72%
|
$0
$0.96 P/Share
|
|
Aug 16
2022
|
Melinda Griffith Director |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$10,000
$1.0 P/Share
|
|
Aug 16
2022
|
Jennifer L. Carter Director |
BUY
Open market or private purchase
|
Direct |
10,500
+25.61%
|
$0
$0.95 P/Share
|
|
Aug 16
2022
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Direct |
115,523
+29.06%
|
$0
$0.97 P/Share
|
|
Aug 15
2022
|
Douglas T. Ross Former CSO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+46.83%
|
-
|
|
Aug 15
2022
|
Gisela Paulsen Former President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
525,000
+43.5%
|
-
|
|
Aug 15
2022
|
Andrew J. Last Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+16.62%
|
-
|
|
Aug 15
2022
|
Alfred D Kingsley Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.2%
|
$0
$0.97 P/Share
|
|
Aug 15
2022
|
Alfred D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+2.41%
|
-
|
|
Aug 15
2022
|
Anish M. John Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Aug 15
2022
|
John Peter Gutfreund |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$0
$0.93 P/Share
|
|
Aug 15
2022
|
John Peter Gutfreund |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Aug 15
2022
|
Melinda Griffith Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+33.33%
|
-
|
|
Aug 15
2022
|
Jennifer L. Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+33.33%
|
-
|
|
Aug 15
2022
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Direct |
34,477
+17.15%
|
$0
$0.93 P/Share
|
|
Aug 15
2022
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.04%
|
-
|
|
Jun 24
2022
|
Cavan M. Redmond Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.64%
|
-
|
|
Jun 24
2022
|
Andrew J. Last Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.93%
|
-
|
|
Jun 24
2022
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.47%
|
-
|